GORE® Septal Occluder European Union Clinical Evaluation
NCT ID: NCT01605851
Last Updated: 2014-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
150 participants
INTERVENTIONAL
2012-05-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of the GORE® Septal Occluder to Treat Ostium Secundum Atrial Septal Defects
NCT01711983
GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients
NCT00738894
Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction
NCT03441971
Long-term Safety Study of the GORE® HELEX® Septal Occluder
NCT00581308
VIATORR Device Registry
NCT05661331
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Closure, Foramen Ovale
Patients undergoing device closure of PFO
Closure, Foramen Ovale
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Closure, Foramen Ovale
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
W.L.Gore & Associates
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aarhus University Hospital
Aarhus, , Denmark
Rigshospitalet
Copenhagen, , Denmark
German Heart Center
Berlin, , Germany
University Medical Center of Freiburg
Freiburg im Breisgau, , Germany
Heidelberg University Hospital
Heidelberg, , Germany
German Heart Center
Munich, , Germany
Hospital Group of San Donato
San Donato, , Italy
Karolinska University Hospital
Stockholm, , Sweden
Leeds Teaching Hospitals
Leeds, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GSO 11-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.